Epilepsy Research
Volume 30, Issue 2 , Pages 91-106, April 1998

Myoclonus and epilepsy in childhood:

1996 Royaumont meeting1

  • Olivier Dulac

      Affiliations

    • Service de Neuropédiatrie, Hopital Saint Vincent de Paul, Université René Descartes and INSERM U29, 82 Av Denfert-Rochereau, Paris, France
    • Corresponding Author InformationCorresponding author.
  • ,
  • Perrine Plouin

      Affiliations

    • Laboratoire de Neurophysiologie Clinique, Hopital Saint Vincent de Paul, Université René Descartes and INSERM U29, 82 Av Denfert-Rochereau, Paris, France
  • ,
  • Allan Shewmon

      Affiliations

    • University of California, Division of Pediatric Neurology, UCLA School of Medicine, 10833 Le Comte Av., Los Angeles, CA 90024, USA
  • ,
  • Contributors to the Royaumont Workshop

Received 20 September 1997; received in revised form 20 November 1997; accepted 23 November 1997.

Abstract 

Sudden and brief involuntary movements of central nervous system (CNS) origin called myoclonus may be cortical (motor strip), thalamocortical (thalamocortical loop) or reticular (caudal reticular formation). Epileptic, cortical and thalamocortical myoclonus are combined with a spike which, when it is focal, needs back-averaging to be demonstrated. Negative myoclonus due to lapse of tone can only be demonstrated during antigravidic posture and may be combined with either a slow wave or the second, positive component of a polyspike-wave. Epileptic myoclonus must be distinguished from epileptic spasms and tonic seizures, and from non-epileptic myoclonus, tics, tremor and chorea. Myoclonus may occur in partial symptomatic (mainly Rasmussen and dysplasia), cryptogenic (frontal) or idiopathic (negative myoclonus in CSWS) epilepsy. Generalized myoclonus is part of inborn errors of metabolism, non-progressive encephalopathy (mainly Angelman) and idiopathic epilepsy (juvenile and infantile benign and severe forms, and myoclonic-astatic epilepsy). Carbamazepine, vigabatrin and eventually lamotrigine may worsen myoclonus whereas it may be improved by benzodiazepines, valproate, lamotrigine, zonisamide and piracetam according to etiology. Pathophysiology must take in account maturation processes, lesions and genetic predisposition. However, precise mechanisms remain unknown and only hypotheses can be proposed, that could clarify the age-related EEG and clinical expression of the various syndromes.

Keywords:  Myoclonus, Childhood, Epilepsy syndromes

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 
  • 1 O. Dulac (Chairman of the Commission of Pediatric Epilepsy), Ch. Dravet (Chairman of the Subcommission of Classification of Pediatric Epilepsy), F. Andermann, R. Appleton, N. Bathien, E. Ben Ari, E. Ben Menachem, S. Berkovic, A. Biraben, M. Catala, C. Chiron, F.B. Dalla Bernardina, J. Donat, F. Dreifuss, K. Farrell, N. Fejerman, A. Corlot, P. Genton, C. Goetz, R. Guerrini, H. Holthausen, C. Marescaux, F. Mauguiére, R. Michelucci, E. Mizrahi, P. Plouin, D. Rating, O. Robain, J. Rothwell, A. Shewmon, H. Shibasaki, D. Schmidt, A. Tassinari, P. Uldall, F. Vigevano, P. Viri, S. Wallace, K. Watanabe.

PII: S0920-1211(97)00099-5

Epilepsy Research
Volume 30, Issue 2 , Pages 91-106, April 1998